cardiovascular-agents and Foot-Diseases

Each horse with laminitis is presented to the veterinarian at a different stage in progression of the condition and with varying severity. The pathogenic timing is often unknown and is difficult to determine. Because timing and severity are related to both the lesion's severity and responsiveness to treatment, these factors are critical to treatment selection and success. It is erroneous to assume that each horse with laminitis should receive each treatment. It is therefore important to ascertain as logically and objectively as possible the pathophysiological stage of development of each horse when it is examined. Therapeutic failure may result from inappropriate interpretation of the clinical signs and pathophysiologic condition of the patient in order to coordinate a treatment regimen.

Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Cardiovascular Agents; Foot Diseases; Hoof and Claw; Horse Diseases; Horses; Inflammation

Topics: Atmospheric Pressure; Cardiovascular Agents; Ergot Alkaloids; Foot Diseases; Gangrene; Humans; Hyperbaric Oxygenation; Oxygen; Toxicology; Vascular Diseases

Topics: Cardiovascular Agents; Foot Diseases; Humans; Muscle Relaxants, Central; Podiatry